Lora Clawson

Assistant Professor

1988 …2018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Lora Clawson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Amyotrophic Lateral Sclerosis Medicine & Life Sciences
Positive-Pressure Respiration Medicine & Life Sciences
Noninvasive Ventilation Medicine & Life Sciences
Decision Making Medicine & Life Sciences
Terminal Care Medicine & Life Sciences
Excitatory Amino Acids Medicine & Life Sciences
Motor Neuron Disease Medicine & Life Sciences
Self Efficacy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1988 2018

Amyotrophic lateral sclerosis–specific quality of life–short form (ALSSQOL-SF): A brief, reliable, and valid version of the ALSSQOL-R

Felgoise, S. H., Feinberg, R., Stephens, H. E., Barkhaus, P., Boylan, K., Caress, J., Clawson, L., Elman, L., Goutman, S. A., Mccluskey, L., Russell, J., Tiryaki, E., Weiss, M. & Simmons, Z., Jan 1 2018, (Accepted/In press) In : Muscle and Nerve.

Research output: Contribution to journalArticle

Amyotrophic Lateral Sclerosis
Statistical Factor Analysis
Quality of Life

A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis

On behalf of the neals consortium, Nov 29 2017, (Accepted/In press) In : Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. p. 1-9 9 p.

Research output: Contribution to journalArticle

Amyotrophic Lateral Sclerosis
Randomized Controlled Trials
Outcome Assessment (Health Care)
Physical Therapists

Medical history of chemotherapy or immunosuppressive drug treatment and risk of amyotrophic lateral sclerosis (ALS)

Kuczmarski, T., Stommel, E. W., Riley, K., Tandan, R., Chaudhry, V., Clawson, L., Caller, T. A., Henegan, P. L., Facciponte, D. N., Bradley, W. G. & Andrew, A. S., Aug 1 2017, In : Journal of Neurology. 264, 8, p. 1763-1767 5 p.

Research output: Contribution to journalArticle

Amyotrophic Lateral Sclerosis
Immunosuppressive Agents
Drug Therapy
Pharmaceutical Preparations

High-dosage ascorbic acid treatment in charcot-marie-tooth disease type 1A results of a randomized, double-masked, controlled trial

Lewis, R. A., McDermott, M. P., Herrmann, D. N., Hoke, A., Clawson, L., Siskind, C., Feely, S. M. E., Miller, L. J., Barohn, R. J., Smith, P., Luebbe, E., Wu, X. & Shy, M. E., 2013, In : JAMA Neurology. 70, 8, p. 981-987 7 p.

Research output: Contribution to journalArticle

Charcot-Marie-Tooth Disease
Ascorbic Acid
Natural History
Medical Futility

Electrical impedance myography as a biomarker to assess ALS progression

Rutkove, S. B., Caress, J. B., Cartwright, M. S., Burns, T. M., Warder, J., David, W. S., Goyal, N., Maragakis, N. J., Clawson, L., Benatar, M., Usher, S., Sharma, K. R., Gautam, S., Narayanaswami, P., Raynor, E. M., Watson, M. L. & Shefner, J. M., Sep 2012, In : Amyotrophic Lateral Sclerosis. 13, 5, p. 439-445 7 p.

Research output: Contribution to journalArticle

Electric Impedance
Clinical Trials